The experimental malaria vaccine PfAMA1 DiCo elicits a broad immune response in humans

19 Apr 2021 | Back to News, Publications and Annual Reports

Image

 

In much of the world, malaria continues to cause high mortality, especially among children. In adults who have survived the various attacks of the malaria parasite on the body, the immune system is trained and can increasingly recognize and neutralize the great diversity of malaria parasites. BPRC scientists investigated whether a vaccine can give the same immune response.

BPRC supports the Parkinson Alliance Netherlands

13 Apr 2021 | Back to News, Publications and Annual Reports

Image

 

Parkinson's disease is the fastest growing brain disorder worldwide. This is partly due to the increasing age of the population, but also in younger age groups the incidence is rising. In 5% of cases there is an hereditary cause, but for the vast majority of patients the cause is unknown. To combat Parkinson's disease, collaboration is important.

Guess what this is

17 Feb 2021 | Back to News, Publications and Annual Reports

Image

 

The picture shows a so-called VAP, or a vascular access point. Patients receiving chemotherapy are often pricked. Poking regularly may cause damage to the blood vessel. That is why patients sometimes get a VAP. Thanks to this subcutaneous implant, a doctor can administer chemotherapy or draw blood, without damaging the blood vessel. Laboratory animals can also benefit from a VAP, for example blood donors.